Close
Nordic 9Nordic 9

InSphero (private company)

Switzerland insphero.com
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechManufacturingPharma
Business model:B2B

InSphero is a Swiss developer of an automation-compatible technology platform used for producing industrial-grade and scalable 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology for pharmaceutical and biotechnology researchers

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to InSphero

Name Criteria
Sweden Pila Pharma
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Cytoki Pharma
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Norway Alginor
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Intrance Medical Systems
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Switzerland Galventa
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Germany Exciva
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
United Kingdom Mytos
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Germany Emergence Therapeutics
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Oncorena
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Germany LenioBio
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top